Fresenius Medical Care AG & Co. KGaA Investor News Investor Relations Else-Kr ner-Str. 1 D-61352 Bad Homburg Contact: Oliver Maier Phone: + 49 6172 609 2601 Fax: + 49 6172 609 2301 E-mail: ir@fmc-ag.com North America: Te

Medical Care announces Resignation of

Lawrence A. Rosen, Chief Financial Officer

Bad Homburg, Germany Fresenius Medical Care AG & Co. KGaA

( the Company ), the world s largest provider of Dialysis Services and Products, today

announced that Lawrence A. Rosen will resign as Member of the Management Board

of Fresenius Medical Care and Chief Financial Officer (CFO) to pursue other

opportunities outside the company. Mr. Rosen will continue in his position with

Fresenius Medical Care for the time necessary to ensure a smooth transition of

the CFO responsibilities. Lawrence A. Rosen has been CFO of Fresenius Medical

Care since November 2003. Fresenius Medical Care expects to name a new Chief

Financial Officer soon.

thank Larry for his significant contributions to our company and wish him all

the best for his new position, said Dr. Ben Lipps, Chief Executive Officer of

Fresenius Medical Care and Chairman of the Management Board. Fresenius Medical

Care continues to have a very strong financial position and Cash Flow

generation and only minor long-term refinancing needs before 2011. We expect to

continue with our strong business performance across all segments and regions

Fresenius Medical Care is the

world s largest integrated provider of products and services for individuals

undergoing dialysis because of chronic kidney failure, a condition that affects

more than 1,770,000 individuals worldwide. Through its network of 2,388

dialysis clinics in North America, Europe, Latin America, Asia-Pacific and

Africa, Fresenius Medical Care provides dialysis treatment to 184,086 patients

around the globe. Fresenius Medical Care is also the world s leading provider

of dialysis products such as hemodialysis machines, dialyzers and related

disposable products. Fresenius Medical Care is listed on the Frankfurt Stock

Exchange (FME, FME3) and the New York Stock Exchange (FMS, FMS/P).

For more information about

Fresenius Medical Care visit the Company s website at www.fmc-ag.com.

This release contains forward-looking

statements that are subject to various risks and uncertainties. Actual results

could differ materially from those described in these forward-looking

statements due to certain factors, including changes in business, economic and

competitive conditions, regulatory reforms, foreign exchange rate fluctuations,

uncertainties in litigation or investigative proceedings, and the availability

of financing. These and other risks and uncertainties are detailed in Fresenius

Medical Care AG & Co. KGaA s reports filed with the U.S. Securities and

Exchange Commission. Fresenius Medical Care AG & Co. KGaA does not undertake any

responsibility to update the forward-looking statements in this release.